Integrum AB (publ) (STO:INTEG.B)

Market Cap	373.35M
Revenue (ttm)	97.31M
Net Income (ttm)	-19.55M
Shares Out	21.33M
EPS (ttm)	-1.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,725
Average Volume	60,115
Open	15.08
Previous Close	15.10
Day's Range	15.08 - 17.54
52-Week Range	12.48 - 61.40
Beta	1.37
RSI	69.39
Earnings Date	Jun 3, 2025

About Integrum AB

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1990
• Employees: 39
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: INTEG.B